| Formulary Chapter 9: Nutrition and blood - Full Section
|
Notes:
This chapter of the formulary is under continual development, please let the team know if you have any comments about the contents: mlcsu.lscformulary@nhs.net.
|
| Useful Links |
 LSCMMG: Bariatric surgery guidelines for prescribing of vitamins and nutritional supplements: Position Statement |
|
LSCMMG: Gluten-Free food products: Position Statement |
|
LSCMMG: Oral Nutritional Supplements in Primary Care |
|
LSCMMG: PKU - Prescribing of Multivitamins & Phenylalanine-free amino acid substitutes for adults and children |
|
NICE CG32: Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition |
|
NICE NG20: Coeliac disease: recognition, assessment and management |
|
NICE NG203: Chronic kidney disease: assessment and management |
| Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
|
|
09.01.01 |
Iron-deficiency anaemias
(1,0)
|
|
09.01.01.01 |
Oral iron
(4,0)
|
|
|
Iron and folic acid
(1,0)
|
|
09.01.01.02 |
Parenteral iron
(3,0)
|
|
09.01.02 |
Drugs used in megaloblastic anaemias
(3,0)
|
|
09.01.03 |
Drugs used in hypoplastic, haemolytic, and renal anaemias
(6,0)
|
|
|
Erythropoietin
(2,0)
|
|
|
Iron overload
(3,0)
|
|
09.01.04 |
Drugs used in autoimmune thrombocytopenic purpura
(7,0)
|
|
09.01.05 |
G6PD deficiency
(0,0)
|
|
09.01.06 |
Drugs used in neutropenia
(2,0)
|
|
09.02 |
Fluids and electrolytes
(0,0)
|
|
09.02.01 |
Oral preparations for fluid and electrolyte imbalance
(0,0)
|
|
09.02.01.01 |
Oral potassium
(3,0)
|
|
|
Potassium removal
(3,0)
|
|
09.02.01.02 |
Oral sodium and water
(1,0)
|
|
|
Oral rehydration therapy (ORT)
(1,0)
|
|
09.02.01.03 |
Oral bicarbonate
(1,0)
|
|
09.02.02 |
Parenteral preparations for fluid and electrolyte imbalance
(0,0)
|
|
09.02.02.01 |
Electrolytes and water
(0,0)
|
|
|
Supplementary preparations
(0,0)
|
|
09.04 |
Oral nutrition
(0,0)
|
|
09.04.02 |
Enteral nutrition
(0,0)
|
|
09.05 |
Minerals
(0,0)
|
|
09.05.01 |
Calcium and magnesium
(0,0)
|
|
09.05.01.01 |
Calcium supplements
(4,0)
|
|
09.05.01.02 |
Hypercalcaemia and hypercalciuria
(2,0)
|
|
09.05.01.03 |
Magnesium
(4,0)
|
|
09.05.02 |
Phosphorus
(0,0)
|
|
09.05.02.01 |
Phosphate supplements
(3,0)
|
|
09.05.02.02 |
Phosphate-binding agents
(4,0)
|
|
09.05.03 |
Fluoride
(1,0)
|
|
09.05.04 |
Zinc
(1,0)
|
|
09.06 |
Vitamins
(1,0)
|
|
09.06.02 |
Vitamin B group
(3,0)
|
|
|
Oral vitamin B complex preparations
(1,0)
|
|
|
Other compounds
(0,0)
|
|
09.06.03 |
Vitamin C
(1,0)
|
|
09.06.04 |
Vitamin D
(5,0)
|
|
|
Vitamin D with Calcium
(0,0)
|
|
09.06.05 |
Vitamin E
(1,0)
|
|
09.06.06 |
Vitamin K
(2,0)
|
|
09.06.07 |
Multivitamin preparations
(3,0)
|
|
|
Vitamin and mineral supplements and adjuncts to synthetic diets
(2,0)
|
|
09.08 |
Metabolic disorders
(0,0)
|
|
09.08.01 |
Drugs used in metabolic disorders
(6,0)
|
|
|
Wilsons disease
(1,0)
|
|
|
Carnitine deficiency
(1,0)
|
|
|
Drugs unsafe for use in acute porphyrias
(0,0)
|
